13F HOLDINGS REPORT
Athyrium Capital Management, LP
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001123292-23-000142
Total Value
$113.6M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Omeros Corp | OMER | 72,979,000 | $44.6M | 39.31% |
| 2 | Biora Inc. | 74319FAB3 | 53,500,000 | $28.0M | 24.62% |
| 3 | Biora Inc. | 74319F305 | 10,929,762 | $23.7M | 20.89% |
| 4 | Omeros Corp | OMER | 11,005,000 | $11.3M | 9.91% |
| 5 | PUMA BIOTECHNOLOGY INC | PBYI | 1,792,114 | $4.7M | 4.15% |
| 6 | RVL PHARMACEUTICALS PLC | G6S41R101 | 14,600,444 | $1.3M | 1.11% |